[141 Pages Report] The overall pharmaceutical robotic systems market is expected to grow from USD 64.37 million in 2016 to USD 119.46 million by 2021, at a CAGR of 13.2% from 2016 to 2021. Benefits offered by robotic systems in pharmaceutical manufacturing is a key factor driving the growth of pharmaceutical robots market. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Market Dynamics

Drivers

Benefits offered by robotic systems in pharmaceutical manufacturing

Conferences and exhibitions to raise awareness of robotic systems in pharmaceutical manufacturing

Restraints

Lack of skilled personnel to work in automated manufacturing units

Opportunities

Increased demand for collaborative robots in manufacturing facilities

Challenges

Manufacturing advanced robotic systems that meet the requirements of consumers in the era of Industrial Internet of Things (IIoT)

Benefits offered by robotic systems in pharmaceutical manufacturing drive the global pharmaceutical robotic systems market

In 2015, the U.S. FDA approved 45 new medicines as compared to 27 in 2013. It also approved 98% of high-risk medical devices in 2014 as compared to 86% in 2013 and 70% in 2012. As the demand for new drugs and medicines grows, pharmaceutical companies are continuously looking for new ways to increase productivity, leading to an increased reliance on automated equipment and robotics. Robotic systems provide various benefits to pharmaceutical manufacturing such as lesser space utilization, reduced production downtime, no labor turnover, enhanced health and safety, better waste management, increased production flexibility, improved production output and product quality, and lower operating costs. With the growing pharmaceutical industry and the various benefits offered by robotic automation, the adoption of robots is likely to increase in the coming years.

The following are the major objectives of the study.

To describe and forecast the pharmaceutical robotic systems market, in terms of value, by type, application, and region

To describe and forecast the pharmaceutical robotic systems market, by region�Asia Pacific (APAC), Europe, North America, and Rest of the World (RoW) along with their respective countries

To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and challenges)

To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To study the complete value chain of pharmaceutical robotic systems

To analyze opportunities in the market for stakeholders by identifying the high-growth segments of the pharmaceutical robotic systems ecosystem

To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing competitive landscape for market leaders

To analyze strategic approaches such as marketing and promotions, expansions, agreements, alliances, collaborations, partnerships, product launches, acquisitions, product enhancements, market developments, funding, restructuration, and rebranding in the pharmaceutical robotic systems market

During this research study, major players operating in the pharmaceutical robotic systems market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the pharmaceutical robots market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

To know about the assumptions considered for the study, download the pdf brochure

Key players considered in the analysis of the pharmaceutical robotic systems market are Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan).

Major Market Developments

In 2016, Kawasaki opened a Tokyo Robot Center Showroom in Odaiba, Tokyo, Japan. The new facility offers robotics-related information.

In 2016, Yaskawa launched the MOTOMAN-MH5BM, a six-axis vertical articulated robot. The robot is ideal for sterile or hygienic environments such as the biomedical field, which includes drug discovery research, pharmaceutical and medical industry, as well as the beverage industry.

In 2016, FANUC collaborated with NVIDIA (U.S.) to implement Artificial Intelligence on the FANUC Intelligent Edge Link and Drive (FIELD) system. This is aimed to increase robotics productivity and bring new capabilities to automated factories across the globe. Moreover, the advances in artificial intelligence aim to allow robots to watch & learn, and improve its capabilities.

In 2016, Mitsubishi established two new Factory Automation ("FA") centers in Italy and South Africa. With this expansion, the company aimed at expanding the FA product support network in Southern Europe and Africa, along with strengthening and accelerating local customer service.

In 2015, ABB established a new robotics plant at its existing facility in Auburn Hills, Michigan. The expansion is aimed at elevating its product offerings and services to robotics customers in the U.S., Mexico, and Canada. With the expansion, the company becomes the first global industrial robotics company to invest in and fully commit to the North American robotics-manufacturing footprint.

Target Audience

Industrial robots manufacturers

Pharmaceutical manufacturing units

Technology investors

Distributors of industrial robots

Market research and consulting firms

Government bodies/municipal corporations

Business research and consulting service providers

Venture capitalists

Community centers

Regulatory bodies

Report Scope

Pharmaceutical Robotic Systems Market, By Type

Traditional Robots Articulated Robots Scara Robots Delta/Parallel Robots Cartesian Robots Other Robots

Collaborative Pharmaceutical Robots

Pharmaceutical Robotic Systems Market, By Application

Traditional Robots

Picking and Packaging

Inspection of Pharmaceutical Drugs

Laboratory Applications

Pharmaceutical Robotic Systems Market, by Region

North America US Canada

Europe Germany Rest of Europe (RoE)

Asia Pacific China Rest of Asia Pacific

Rest of the World (RoW)

Critical questions which the report answers

What are new technology trends which the pharmaceutical robotic systems companies are exploring?

Which are the key players in the market and how intense is the competition?

Available Customizations

Based on the given market data, MarketsandMarkets offers customizations in the reports as per the client�s specific requirements. The available customization options are as follows:

Geographic Analysis

Further country-wise breakdown of the market in RoW region into Latin America and Middle East & Africca

Company Information

Detailed analysis and profiling of additional market players (Up to 5)

The overall pharmaceutical robotic systems market is expected to grow from grow from USD 64.37 million in 2016 to USD 119.46 million by 2021, at a CAGR of 13.2% from 2016 to 2021. Benefits offered by robotic systems in pharmaceutical manufacturing is a key factor driving the growth of pharmaceutical robots market.

A robotic system is a type of automation that has multiple axes of motion and can be programmed to perform a function. Some of the benefits of automation include efficiency, saving workers from hazardous environments or repetitive tasks, reducing training overhead, eliminating human error, increasing repeatability and reproducibility, and in cleanrooms, removing the potential for human contamination.

On the basis of application, the global pharmaceutical robotic systems market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications. The picking and packaging segment accounted for the largest share of the global pharmaceutical robotic systems market. Factors such as demand for personalized packaging configurations and advantages of robots in pharmaceutical manufacturing such as high speed, accuracy, ability to track and trace, error-free operation, fewer accidents, and better utilization of the floor space are contributing to the large share of the picking and packaging segment.

The pharmaceutical robotic systems market in APAC is expected to grow at the highest CAGR during the forecast period owing to factors such as the increase in domestic industrial robots companies, flourishing pharmaceutical industry, increasing number of conferences and exhibitions, investments and funding in the industrial robots industry, and Japan�s Robot Strategy.

Applications in picking and packaging, inspection of pharmaceutical drugs, and laboratory applications drive the growth of pharmaceutical robotic systems market

Picking and Packaging

Automation is becoming an increasingly important part of pharmaceutical manufacturing. A robotic system is a type of automation. Robots offer various advantages, such as high efficiency, save workers from hazardous environments and repetitive tasks, reduce training overheads, eliminate human errors, and increase repeatability and reproducibility. The common applications of robots include pick and place operations that often use SCARA robots.

Inspection of Pharmaceutical Drugs

Inspection of pharmaceutical drugs is an important step to ensure the quality of drugs that are provided to the end consumers. Automatic inspection, as part of a robotic system, enables 100% part inspection. A robotic system consists of several cameras which capture images and identify minor imperceptible flaws in products. This ensures that only perfect products are sent out for packaging. The vision-sensing technology in robots is used in Pharmaceutical Packaging to verify serialization numbers for compliance with track-and-trace regulations.

Laboratory Applications

Robots are increasingly being used in laboratories to improve quality and efficiency. Many tests associated with research, discovery, and development involve repetitive tasks such as moving fluids between wells in a plate. Pharmaceutical laboratories are now using robots to perform these tests as they are easy to automate. Moreover, robots offer a high degree of consistency and accuracy executing test protocols, while at the same time allowing researchers to focus on higher-value tasks. The success of robots in pharmaceutical laboratories has encouraged companies to incorporate the machines into closely-related production operations such as pilot and small-batch manufacturing lines.

Critical questions the report answers:

Where will all these developments take the industry in the mid to long term?

What are the upcoming industry applications for pharmaceutical robotic systems?

Lack of skilled personnel is a major factor restraining the growth of the market. Industrial Robotics is a multidisciplinary field where acquiring and retaining qualified workers is a major issue. There is a scarcity of people specializing in disciplines such as electrical, embedded, software, and mechanical engineering, which make up industrial robotics. There is also a deficit of highly qualified employees with specific educational backgrounds and skills, especially those needed to produce high value-added robots integrated with advanced technologies. In developing economies such as India, Thailand, and Brazil, there is a shortage of skilled labor to handle industrial robots. This is because knowledge of four to five engineering disciplines is required to become an expert in this field, and faculty shortages are a major problem in these countries. Moreover, there are limited branches of engineering which focus on robotics. Thus, the dearth of skilled talent inhibits the growth of robot automation in the pharmaceutical industry.

Key players in the Pharmaceutical Robots Market include Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan). These players are increasingly undertaking marketing and promotions, expansions, agreements, alliances, collaborations, partnerships, product launches, acquisitions, product enhancements, market developments, funding, restructuration, and rebranding to develop and introduce new technologies and products in the market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst